Russia has patented its second vaccine against COVID-19, developed by the State Research Center for Virology and Biotechnology Véktor and called EpiVacCorona, as reported on Wednesday by the Federal Intellectual Property Service (Rospatent).
“Rospatent experts have completed the second round examination of applications for inventions related to the vaccine against the coronavirus SARS-CoV 2. The State Research Center for Virology and Biotechnology Véktor received patents for the vaccine it created against COVID-19, “the agency said in a statement.
The EpiVacCorona contains synthetic peptide antigens, virus fragments.The vaccine based on these antigens generates an immune response and contributes to the development of immunity against COVID-19, Rospatent noted.
The Russian Government foresees register your second vaccination on October 15, phase II of clinical trials ended today. The first Russian vaccine, Sputnik V, was registered on August 11 and is currently in phase III trials, the first results of which are expected in October or November.
Meanwhile, Russia is experiencing a new increase in coronavirus cases and amounted to 8,481 new cases in the last 24 hours. In Moscow, the focus of the pandemic in the country, There were 2,308 new cases of COVID-19 in the last day. The mayor of the Russian capital, Sergei Sobianin, has recommended that those over 65 stay at home and that companies return to teleworking, and has ordered the closure of schools in the city for two weeks.